| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
2 companies
Coen Steven P. serves as a See Remarks at DNA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 27 sells. Those positions are worth an estimated $583K at current prices.
Historically, Coen Steven P.'s trades have earned a strong insider score of 70/100 across 18 rated trades. Over a 12-month horizon, 69.2% of those trades were profitable, with an average 12-month return of +4.1%.
The biggest single holding is DNA (~$509K) as See Remarks. The recent filings there lean toward selling, a net 227,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 333 | $7.58 | $2,522.81 | -4.9% | +68.4% | +51.9% | |
| Oct 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 306 | $8.35 | $2,555.41 | -4.8% | +22.7% | +93.8% | |
| Sep 12, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 316 | $6.17 | $1,950.35 | -5.3% | +70.7% | +59.6% | |
| Aug 2, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 17,486 | $0.29 | $5,018.48 | -7.8% | -39.4% | -3.1% | |
| Jul 2, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 13,520 | $0.33 | $4,407.52 | -6.5% | -41.2% | -8.7% | |
| Jun 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 13,440 | $0.55 | $7,378.56 | -7.0% | -71.8% | -65.5% | |
| May 2, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | See Remarks | Sale+OE | 131,928 | $0.85 | $111,479.16 | -44.8% | -55.9% | -79.6% |